Search

everythinglearnresearchcommunity

for

Search:↓

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

PGD2 stops hair growth and is higher in bald men with AGA.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

PRFM may help treat hair loss, especially in mild cases.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

PPARγ is crucial for skin health but can have both beneficial and harmful effects.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.